Guardant Health to Participate in Upcoming March Investor Conferences

Rhea-AI Summary

Guardant Health, a leader in precision oncology, will participate in two upcoming investor conferences. The first is the Citi 2023 Healthcare Services, MedTech, Tools & HCIT Conference in New York City on March 1, 2023, at 3:30 p.m. Eastern Time. The second is the Cowen 43rd Annual Health Care Conference in Boston on March 8, 2023, at 10:30 a.m. Eastern Time. Live and archived webcasts of both presentations will be available on the Guardant Health website. The company aims to improve cancer care through advanced analytics and proprietary tests like Guardant360 and Shield.

PALO ALTO, Calif.--(BUSINESS WIRE)-- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating in the following investor conferences.

• Citi 2023 Healthcare Services, MedTech, Tools & HCIT Conference in New York City, NY
  Fireside Chat on Wednesday, March 1^st at 3:30 p.m. Eastern Time / 12:30 p.m. Pacific Time

• Cowen 43rd Annual Health Care Conference in Boston, MA
  Fireside Chat on Wednesday, March 8^th at 10:30 a.m. Eastern Time / 7:30 a.m. Pacific Time

Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: www.guardanthealth.com.

About Guardant Health

Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary tests, vast data sets and advanced analytics. The Guardant Health oncology platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs across all stages of the cancer care continuum. Guardant Health has commercially launched Guardant360^®, Guardant360 CDx, Guardant360 TissueNext™, Guardant360 Response™, and GuardantINFINITY™ tests for advanced-stage cancer, and Guardant Reveal™ for early-stage cancer. The Guardant Health screening portfolio, including the commercially launched Shield™ test, aims to address the needs of individuals eligible for cancer screening. For more information, visit guardanthealth.com and follow the company on LinkedIn and Twitter.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230217005075/en/

Investor Contact:

Alex Kleban

investors@guardanthealth.com

+1 657-254-5417

Media Contact:

Michael Weist

press@guardanthealth.com

+1 317-371-0035

Source: Guardant Health, Inc.

FAQ

What is Guardant Health's participation in the Citi 2023 Healthcare Services Conference?

Guardant Health will participate in the Citi 2023 Healthcare Services, MedTech, Tools & HCIT Conference in New York City on March 1, 2023, at 3:30 p.m. Eastern Time.

When is the Cowen 43rd Annual Health Care Conference?

The Cowen 43rd Annual Health Care Conference will take place in Boston on March 8, 2023, at 10:30 a.m. Eastern Time.

How can I access the webcasts of Guardant Health's presentations?

Webcasts of Guardant Health's presentations will be available live and archived on the 'Investors' section of their website.

What is the focus of Guardant Health's oncology platform?

Guardant Health's oncology platform focuses on improving patient outcomes and lowering healthcare costs through its proprietary tests and advanced analytics.

What tests does Guardant Health offer for cancer care?

Guardant Health offers several tests including Guardant360, Guardant Reveal, and the Shield test for cancer screening.